468 • Хронический панкреатит

91. L owenfels А. В., Maisonneuve P., Cavallini G. et al. Pancreatitis and the risk of pancreatic cancer // New Engl. J. Med.— 1993.- Vol. 328,- P. 1433-1437.

92. Lowenfels А. В., Maisonneuve P., DiMagno E. P. et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group //J. Natl. Cancer. Inst.— 1997.-Vol. 89.- P. 442-446.

93. Luttges J., Schlehe В., Menke M. A., Vogel I. et al. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium // Cancer.— 1999.- Vol. 85.- P. 1703-1710.

94. Machado M. C. C, Da Cunha J. E. M., Bacchella T. et al. Acute pancreatic necrosis in chronic alcoholic pancreatitis // Dig. Dis. Sci.— 1984.—Vol. 29.— P. 709—713.

95. Mack T. M., Yu M. C, Hanisch R. et.al. Pancreas cancer and smoking, beverage consump­ tion, and past medical history // J. Nat.Cane.Inst.— 1986.— Vol. 76.— P. 49—68.

96. Madsen O. D., Jensen J., Blume N. et al. Pancreatic development and maturation of the is­ let beta cell studies of pluripotent islet cultures // Eur. J. Biochem.— 1996.— Vol. 242.— P. 435-445.

97. Matsubayashi H., Watanabe H., Nishikura K. et al. Determination of pancreatic ductal car­ cinoma histogenesis by analysis of mucous quality and K-ras mutation // Cancer.— 1998.— Vol. 82.-P. 651—660.

98. Miyake H., Harada H., Ochi K. et al. Prognosis and prognostic factors in chronic pancrea­ titis // Dig. Dis. Sci.— 1989.- Vol. 34.- P. 449-455.

99. Moeller Jensen O., Estuve J., Moeller H., Renard H. Cancer in the European Community and its member states // Eur. J. Cancer.— 1990,— Vol. 26.— 1167—256.

100. Mohan V. et al. Benefit of oral pancreatic enzyme therapy in the control of diabetes melli- tus in tropical calculous pancreatitis // Pancreas,— 1997.—Vol. 15.— P. 446.

101. Mohan V., Poongothai S., Pitchumoni C. S. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis // Int. J. Pancreatol.— 1998.— Vol. 24.-P. 19-22.

102. Moskaluk C, Kern S. Molecular genetics of pancreatic cancer.—In: Pancreatic Cancer / Ed. H. Reber.- New Jersey, 1998.- P. 3-20.

103. Motojima K., Urano Т., Nogato Y. et al. Detection of point mutations in the kirsten-ras on- cogene provides evidence for the multicentricity of pancreatic cancer // Ann.Surg.— 1993.-Vol. 217,-P. 138.

104. Nakada Y, Saito D., Ohzawa K. et al. Antisense oligonucleotides specific to mutated K-ras genes inhibit invasiveness of human pancreatic cancer cell lines // Pancreatology.— 2001.-Vol. l.-P. 314-319.

105. Nakamori S., Okami J., Shiozaki K. et al. K-ras gene mutations in plasma DNA are poten­ tial prognostic indicators for patients with pancreatic cancer // Proc.ASCO.— 1999.— P. 967.

106. Nakamori S., Yashima K., Murakami Y. et al. Association p-53 gene mutations with short survival in pancreatic adenocarcinoma // Jpn J. Cane. Res.— 1996.— Vol. 86.— P. 174— 181.

107. National Cancer Institute. Annual Cancer Statistics Review 1973—1988 (NIH publication N.o.91— 2789).— Bethesda, MD: Department of Health and Human Services, 1991.

108. Neglia J. P., FitzSimmons S. C, Maisonneuve P. et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group // N. Engl. J. Med.— 1995.— Vol. 332.- P. 494—499.

109. Niederhuber J. E., Brennan M. F., Menck H. R. The National Cancer Data Base report on pancreatic cancer // Cancer.— 1995.— Vol. 76.— P. 1671 — 1677.

110. Ozawa F., Friess H., Tempia-Caliera A. et al. Growth factors and their receptors in pancre­ atic cancer // Teratog. Carcinog. Mutagen.— 2001,— Vol. 21.— P. 27—44.

111. Parkin D. M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000//Int. J. Cancer.-2001.-Vol. 94.—P. 153-156.

112. Parkin D. M., Pizani P., FerlayJ. Estimates of the worldwide incidence of eighteen major cancers in 1985 // Int. J. Cane— 1993.-Vol. 54,- P. 594-606.

113. Petrin P., Andreoli A., Antoniutti M. et al. Surgery for chronic pancreatitis: what quality of life ahead? // World J. Surg,— 1995,- Vol. 19,- P. 398-402.

114. Petrozzo J. A., Dutta S. K., Latham P. S. et al. Prevalence and natural history of distal com­ mon bile duct stenosis in alcoholic pancreatitis // Dig. Dis. Sci.—1984.—Vol. 29.— P.890—895.

115. Pictate R., Rutter W. J. Development of embryonic endocrine pancreas // Handbook of physiology.— Baltimore: Williams & Wilkins, 1972.— P. 25—66.

116. Pour P. M. The silent killer// Int. J. Pancreatol.—1991.—Vol. 10,- P. 103-104.